Articles from The Fly (September 12, 2022)

Title	Author	Type	Words
3D Systems adds chief corporate development officer to Andrew Johnson's title.			314
Adagio Therapeutics announces corporate name change to Invivyd.			199
Agenus initiates botensilimab Phase 2 ACTIVATE trials.			298
Akoustis reports Q4 non-GAAP EPS (26c), consensus (19c).		Financial report	174
Alector initiates Phase 1 clinical trial of AL044 for treatment of Alzheimer's.			223
Allakos announces initiation of Phase 2b trial of subcutaneous lirentelimab.			181
American Express CFO feels 'even better' now about multiyear growth trajectory.			450
American Express CFO says consumer spending momentum holding up.			380
American Rebel CEO Ross provides corporate update in letter to stockholders.			326
AmerisourceBergen to acquire PharmaLex, sees accretion.			185
Amgen announces 30% ORR in CodeBreaK 101 study at ESMO.			243
Amgen announces CodeBreaK 200 trial meets primary endpoint at ESMO.			307
Amsylyx: Data shows synergistic effect of AMX0035 versus individual compounds.			219
Anika announces initial surgeries performed using the X-Twist Fixation System.			165
AppLovin will not submit revised proposal to combine with Unity.			151
Aptose Biosciences announces new G3 formulation of luxeptinib.			307
Arko Corp. announces agreement to acquire all assets of TEG for $375M.			303
Ascendis Pharma announces new Week 110 data from Phase 2 PaTH Forward Trial.			236
Aspira Women's Health announces publication of MIA2G study.		Clinical report	204
Astellas Pharma, Seagen, Merck report results from phase 1b/2 EV-103 trial.			200
Astellas, Seagen and Merck give PADCEV trial results with KEYTRUDA in la/mUC.			218
AstraZeneca's Phase III trial of Imfinzi shows meaningful benefit in BTC.			191
Avita Medical announces Recell System trial meets primary effectiveness endpoint.			204
Ayala presents interim data from RINGSIDE phase 2/3 trial of AL102.			417
BioMarin reports phase 3 BMN 270 study participant diagnosed with B-ALL.			389
Bluebird Bio says Jason Cole, Chief Strategy and Financial Officer, to leave.			156
Can-Fite : New psoriasis data showing "superior' safety & efficacy presented.			264
Centessa announces NHPs PK, safety data for LB101.			248
Cheniere Energy announces '20/20 Vision' long-term capital allocation plan.			320
CleanTech Acquisition, Nauticus Robotics complete business combination.			288
ContraFect announces multiple publications for each of the company's lysins.			285
ContraFect announces presentation of data from study using LysinDAIR.		Clinical report	313
Crestwood divests Marcellus assets to Antero Midstream for $205M in cash.			163
CytomX Therapeutics announces Phase 1 data for anti-CTLA-4 probody.			162
Dish announces national linear programmatic partnership with SeaChange.			207
Dyne Therapeutics highlights DM1, DMD clinical programs.			403
Electronic Arts, Koei Tecmo announce partnership on new hunting game.			169
Energy Action:.			172
Energy Action:.			177
Enlivex announces new preclinical data in murine mesothelioma model.			369
Entera Bio reports results from Phase 2 study of EB613.			302
Essential Properties Realty Trust announces partnership with Budderfly.			177
Faraday Future up 9% as FF Top demands resignation of Executive Chair Swenson.			270
FEXD a SPAC announces two fintech acquisitions.			294
Fortuna Silver Mines provides update on Seguela gold project exploration.			216
Forward Air reports QTD revenue per shipment up 16%.			191
Fury and Newmont finish JV interests consolidation, targets defined.			272
FX Action: the DXY dollar index remains softer.			295
Gilead TAF IP settlement 'a pretty big deal,' says Wells Fargo.			156
Great Southern Homes to become public through DiamondHead Holdings merger.			606
Gritstone presents initial Phase 2 data from its SLATE program.			382
GT Biopharma announces highlights from GTB-5550 study.			172
Hepion announces initiation of dosing in Phase 2 ALTITUDE-NASH trial.		Clinical report	297
InMed announces $6M private placement priced at premium to market.			235
Innovative Solutions adopts stockholders rights plan.			201
Invivyd announces multiple next generation COVID-19 antibody candidates.			334
KBR awarded $38M Defense Logistics Agency contract.			214
Keros Therapeutics presents additional data from Phase 1 trial of KER-012.			213
Kiniksa closes global license agreement with Genentech for vixarelimab.			181
Light Street Capital urges Zendesk Board to delay vote, engage shareholders.			226
Market Update:.			173
Market Update:.			225
Matrix Service delays Q4 report, 10-K amid review of internal controls.			214
Mereo BioPharma reports clinical update, biomarker data from ACTIVATE.			455
Mersana Therapeutics announces FDA Fast Track designation to XMT-1660.			210
MiMedx's EPIFIX receives reimbursement approval in Japan.			225
NortonLifeLock completes merger with Avast.			153
NuCana presents data on NUC-3373 at ESMO meeting.			326
NuCana: NUC-7738 showed 'encouraging' anti-tumor activity in Phase 1 trial.			179
Onconova announces updated data from Phase 1/2 a trial of rigosertib.			293
Oracle CEO expects Cerner to 'positively impact' revenue, EPS in coming quarters.		Financial report	313
Orezone Gold pours first gold at Bombore mine.			194
Patriot One Technologies selected by SAP Center as San Jose.			178
Peloton co-founders John Foley, Hisao Kushi to step down.			159
Pfizer, BioNTech receive positive CHMP opinion for bivalent Covid vaccine.			194
Plus Therapeutics presents data from Phase 1 ReSPECT-GBM trial.			388
Ra Medical Systems enters merger agreement with Catheter Precision.			505
Regencell Bioscience announces interim results from second TCM efficacy trial.			496
Regeneron announces Libtayo trial meets primary endpoint at ESMO.			284
ReWalk announces German Federal Social Court hearing on exoskeleton device.			223
Roku announces 2022 Roku Express, all-new Roku Wireless Bass.			203
SeqLL announces peer-reviewed application of its single-molecule technology.			216
Shawcor to rebrand, focus on infrastructure tech, explore strategic alternative.			324
SL Green Realty announces acquisition of 245 Park Avenue.			186
SL Green Realty announces sales of commercial condominium for $300.4M.		Financial report	156
Starbucks announces student loan management, savings programs.			252
Target announces exclusive multiyear agreement with FAO Schwarz.			319
Telos upgraded to Outperform from Neutral at Wedbush.			159
Theratechnologies announces publication of preclinical study of TH1902.			371
Titan Medical signs definitive agreement with Medtronic.			164
Treasury Action: yields are lower.			164
Treasury's $41 B 3-year auction was soft.			185
Trio Petroleum files for IPO, seeks to list on NYSE American under symbol 'TPET'.			258
TRX Gold reports preliminary Q4 production of 3,619 ounces of gold.			348
Twitter says Musk's third purported termination invalid, intends to enforce deal.			254
U.S. CPI is the near-term focus.			181
Urban-Gro announces $2M stock repurchase program.			155
Vaxxinity initiates rolling submission for UB-612 COVID-19 vaccine with MHRA.			161
Vertex provides update on Alabama Refinery renewable diesel conversion project.			317
Vista Gold provides update on strategic process on Mt Todd gold project.			203
Wells Fargo to pay $145M in DOL 401(k) settlement.			159
Wendy's advance may have been tied to Peltz hopes, says Gordon Haskett.			160
XL Fleet completes acquisition of Spruce Power for $58M, assumption of debt.			236
Yoshitsu to use new warehouse in Hong Kong to support expansion.			160
Zendesk reiterates view that consortium acquisition provides superior value.			386
Zymeworks reports preliminary Phase 1 ZW49 trial results.			304